X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (54264) 54264
Newsletter (260) 260
Book Chapter (239) 239
Magazine Article (213) 213
Dissertation (79) 79
Publication (78) 78
Conference Proceeding (32) 32
Book / eBook (26) 26
Newspaper Article (26) 26
Book Review (25) 25
Reference (12) 12
Web Resource (12) 12
Transcript (6) 6
Government Document (4) 4
Journal / eJournal (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34627) 34627
male (21184) 21184
angiotensin-converting enzyme inhibitors - therapeutic use (18116) 18116
animals (15904) 15904
female (15564) 15564
index medicus (13426) 13426
middle aged (11073) 11073
aged (9403) 9403
hypertension (9145) 9145
hypertension - drug therapy (9090) 9090
angiotensin-converting enzyme inhibitors - pharmacology (8820) 8820
rats (8082) 8082
cardiac & cardiovascular systems (7749) 7749
adult (7160) 7160
pharmacology & pharmacy (7075) 7075
blood pressure - drug effects (6729) 6729
angiotensin (6077) 6077
peripheral vascular disease (5787) 5787
antihypertensive agents - therapeutic use (5329) 5329
angiotensin-converting enzyme (5265) 5265
angiotensin-converting enzyme inhibitors (5251) 5251
risk factors (4698) 4698
heart failure - drug therapy (4491) 4491
treatment outcome (4456) 4456
blood-pressure (4411) 4411
mortality (4141) 4141
captopril (4108) 4108
heart failure (3937) 3937
angiotensin-converting enzyme inhibitors - adverse effects (3929) 3929
medicine, general & internal (3909) 3909
adrenergic beta-antagonists - therapeutic use (3809) 3809
hypertension - physiopathology (3752) 3752
drug therapy, combination (3707) 3707
angiotensin-converting enzyme inhibitors - administration & dosage (3619) 3619
ace inhibitors (3609) 3609
renin-angiotensin system - drug effects (3572) 3572
blood pressure (3507) 3507
enzymes (3444) 3444
renin-angiotensin system (3425) 3425
urology & nephrology (3365) 3365
converting enzyme-inhibitors (3229) 3229
enalapril (3023) 3023
time factors (2970) 2970
angiotensin converting enzyme (2807) 2807
biochemistry & molecular biology (2717) 2717
calcium channel blockers - therapeutic use (2554) 2554
aged, 80 and over (2436) 2436
research (2423) 2423
hypertension - complications (2418) 2418
myocardial-infarction (2397) 2397
angiotensin receptor antagonists (2392) 2392
captopril - pharmacology (2361) 2361
mice (2345) 2345
drug therapy (2344) 2344
dose-response relationship, drug (2287) 2287
diuretics - therapeutic use (2209) 2209
double-blind method (2209) 2209
angiotensin ii (2207) 2207
expression (2200) 2200
analysis (2170) 2170
antihypertensive agents - pharmacology (2167) 2167
angiotensin ii type 1 receptor blockers - therapeutic use (2165) 2165
converting enzyme-inhibition (2123) 2123
therapy (2093) 2093
renin-angiotensin system - physiology (2077) 2077
peptidyl-dipeptidase a - metabolism (2043) 2043
disease (2034) 2034
heart-failure (1998) 1998
diabetes (1994) 1994
heart failure - physiopathology (1994) 1994
care and treatment (1975) 1975
risk (1965) 1965
physiology (1956) 1956
rats, sprague-dawley (1938) 1938
follow-up studies (1896) 1896
medicine & public health (1861) 1861
bradykinin (1831) 1831
prognosis (1816) 1816
enalapril - therapeutic use (1813) 1813
health aspects (1804) 1804
retrospective studies (1788) 1788
prospective studies (1748) 1748
randomized controlled trials as topic (1713) 1713
rats, wistar (1701) 1701
system (1692) 1692
renin (1690) 1690
clinical trials as topic (1687) 1687
physiological aspects (1666) 1666
hemodynamics - drug effects (1651) 1651
prevention (1636) 1636
inhibitors (1630) 1630
enzyme inhibitors (1617) 1617
angiotensin-ii (1615) 1615
endocrinology & metabolism (1609) 1609
kidney - drug effects (1586) 1586
captopril - therapeutic use (1583) 1583
disease models, animal (1561) 1561
disease progression (1522) 1522
angiotensin-converting enzyme inhibitor (1516) 1516
inhibition (1515) 1515
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (50878) 50878
Japanese (1123) 1123
French (859) 859
Russian (779) 779
German (742) 742
Spanish (301) 301
Chinese (294) 294
Polish (215) 215
Italian (180) 180
Portuguese (133) 133
Danish (86) 86
Hungarian (85) 85
Czech (83) 83
Dutch (76) 76
Norwegian (56) 56
Korean (42) 42
Finnish (30) 30
Slovak (29) 29
Turkish (24) 24
Swedish (23) 23
Ukrainian (23) 23
Hebrew (22) 22
Romanian (19) 19
Serbian (18) 18
Croatian (14) 14
Lithuanian (13) 13
Persian (6) 6
Bosnian (4) 4
Bulgarian (4) 4
Slovenian (3) 3
Belarusian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of allergy and clinical immunology, ISSN 0091-6749, 2013, Volume 131, Issue 6, pp. 1491 - 1493.e25
Journal Article
European heart journal, ISSN 1522-9645, 2012, Volume 33, Issue 16, pp. 2088 - 2097
textabstractAimsRenin-Angiotensin-Aldosterone system (RAAS) inhibitors are well established for the reduction in cardiovascular morbidity, but their impact on all-cause mortality in hypertensive patients is uncertain... 
Hypertension | ARB | Mortality | ACE inhibitor | Meta-analysis | Humans | Middle Aged | Hypertension - drug therapy | Male | Antihypertensive Agents - therapeutic use | Cause of Death | Randomized Controlled Trials as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Female | Renin-Angiotensin System - drug effects | Aged | Hypertension - mortality | Clinical Research
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2018, Volume 71, Issue 13, pp. 1474 - 1482
...) inhibitors as first-choice therapy, whereas angiotensin receptor blockers (ARBs) are merely considered an alternative for ACE inhibitor–intolerant patients... 
angioedema | blood pressure | heart failure | chronic kidney disease | left ventricular hypertrophy | angiotensin receptor blocker | coronary heart disease | adverse events | cough | diabetes | hypertension | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | RANDOMIZED-TRIALS | CARDIOVASCULAR EVENTS | VENTRICULAR SYSTOLIC FUNCTION | RECEPTOR BLOCKERS | ANTIHYPERTENSIVE EFFICACY | BLOOD-PRESSURE | ACE-INHIBITORS | HIGH-RISK | Angioedema - epidemiology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Hypertension - drug therapy | Renin-Angiotensin System - physiology | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Animals | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Angioedema - chemically induced | Renin-Angiotensin System - drug effects | Blood Pressure - drug effects | Blood Pressure - physiology | Cardiovascular Diseases - chemically induced | Clinical Trials as Topic - methods | Hypertension - epidemiology | Drug Therapy, Combination | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects | Heart | Hypertension | Medical colleges | Mortality | Coronary heart disease | Cardiovascular agents | Hospitals | Chronic kidney failure | Analysis | Cardiac patients | Angiotensin | Cardiology | ACE inhibitors | Myocardial infarction | Angiotensin-converting enzyme inhibitors | End-stage renal disease | Enzyme inhibitors | Peptidyl-dipeptidase A | Blood pressure | Drug therapy | Heart diseases | Cerebral infarction | Stroke | Angioedema | Risk analysis | Disease control | Patients | Inhibitors | Renal failure | Infarction | Kidney diseases | Diabetes | Cardiovascular diseases
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
... blockers, angiotensin-converting-enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 5, pp. 418 - 425
Journal Article
Diabetes, ISSN 0012-1797, 03/2012, Volume 61, Issue 3, pp. 549 - 559
Journal Article